EMAIL THIS PAGE TO A FRIEND

PloS one

In vitro metabolism of 20(R)-25-methoxyl-dammarane-3, 12, 20-triol from Panax notoginseng in human, monkey, dog, rat, and mouse liver microsomes.


PMID 24736630

Abstract

The present study characterized in vitro metabolites of 20(R)-25-methoxyl-dammarane-3β, 12β, 20-triol (20(R)-25-OCH3-PPD) in mouse, rat, dog, monkey and human liver microsomes. 20(R)-25-OCH3-PPD was incubated with liver microsomes in the presence of NADPH. The reaction mixtures and the metabolites were identified on the basis of their mass profiles using LC-Q/TOF and were quantified using triple quadrupole instrument by multiple reaction monitoring. A total of 7 metabolites (M1-M7) of the phase I metabolites were detected in all species. 25(R)-OCH3-PPD was metabolized by hydroxylation, dehydrogenation, and O-demethylation. Enzyme kinetic of 20(R)-25-OCH3-PPD metabolism was evaluated in rat and human hepatic microsomes. Incubations studies with selective chemical inhibitors demonstrated that the metabolism of 20(R)-25-OCH3-PPD was primarily mediated by CYP3A4. We conclude that 20(R)-25-OCH3-PPD was metabolized extensively in mammalian species of mouse, rat, dog, monkey, and human. CYP3A4-catalyzed oxygenation metabolism played an important role in the disposition of 25(R)-OCH3-PPD, especially at the C-20 hydroxyl group.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

C3735 Cytochrome P450 human, 1A1 Isozyme Microsomes, with P450 Reductase, recombinant, expressed in baculovirus infected insect cells (BTI-TN-5B1-4)
C5614 Cytochrome P450 human, 1A2 Isozyme Microsomes, with P450 Reductase and cytochrome b5, recombinant, expressed in baculovirus infected insect cells (BTI-TN-5B1-4)
C3860 Cytochrome P450 human, 1B1 Isozyme Microsomes, with P450 Reductase, recombinant, expressed in baculovirus infected insect cells (BTI-TN-5B1-4)
C5740 Cytochrome P450 human, 2E1 isozyme microsomes, with P450 Reductase and cytochrome b5, recombinant, expressed in baculovirus infected insect cells (BTI-TN-5B1-4)
C4982 Cytochrome P450 human, 3A4 isozyme microsomes, with P450 reductase and cytochrome b5, recombinant, expressed in baculovirus infected insect cells (BTI-TN-5B1-4)
C4985 Cytochrome P450 human, 4F2 isozyme microsomes, with P450 Reductase and cytochrome b5, recombinant, expressed in baculovirus infected insect cells (BTI-TN-5B1-4)
C5110 Cytochrome P450 human, 4F3A isozyme microsomes, with P450 Reductase and cytochrome b5, recombinant, expressed in baculovirus infected insect cells (BTI-TN-5B1-4)
C5235 Cytochrome P450 human, 4F3B isozyme microsomes, with P450 Reductase and cytochrome b5, recombinant, expressed in baculovirus infected insect cells (BTI-TN-5B1-4)
K1003
Ketoconazole, ≥98% (HPLC)
C26H28Cl2N4O4
1356508
Ketoconazole, United States Pharmacopeia (USP) Reference Standard
C26H28Cl2N4O4
K0600000
Ketoconazole, European Pharmacopoeia (EP) Reference Standard
C26H28Cl2N4O4
UC280
Ketoconazole
C26H28Cl2N4O4
PHR1385
Ketoconazole, Pharmaceutical Secondary Standard; Certified Reference Material
C26H28Cl2N4O4
PHR1488
Quercetin, Pharmaceutical Secondary Standard; Certified Reference Material
C15H10O7 · xH2O
1592409
Quercetin, United States Pharmacopeia (USP) Reference Standard
C15H10O7 · 2H2O
Q3625
Quinidine, anhydrous
C20H24N2O2
22600
Quinidine, crystallized, ≥98.0% (dried material, NT)
C20H24N2O2
S0758
Sulfaphenazole, ≥98%
C15H14N4O2S
UC166
Sulfaphenazole, ≥98% (HPLC)
C15H14N4O2S